Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 2-phenylethanol Odor Exposure on Ictal Apneic Episode Occurrence Rate in Patients With Epilepsy
NCT07116421Phase 1Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jul 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of phenethyl alcohol in epilepsy and sudden unexpected death in epilepsy (SUDEP) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Number of ictal episodes at 24 hours and Number of apneic episodes at 24 hours. Started Jul 2025; status: recruiting.
02
Drugs
phenethyl alcohol
03
Conditions
epilepsysudden unexpected death in epilepsy (SUDEP)
Beyond the preview
Go deeper on NCT07116421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116421.